Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 2
2006 4
2007 6
2008 11
2009 17
2010 24
2011 17
2012 18
2013 14
2014 25
2015 27
2016 28
2017 23
2018 14
2019 38
2020 41
2021 36
2022 28
2023 39
2024 29
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Results by year

Filters applied: . Clear all
Page 1
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
Franceschi E, Hofer S, Brandes AA, Frappaz D, Kortmann RD, Bromberg J, Dangouloff-Ros V, Boddaert N, Hattingen E, Wiestler B, Clifford SC, Figarella-Branger D, Giangaspero F, Haberler C, Pietsch T, Pajtler KW, Pfister SM, Guzman R, Stummer W, Combs SE, Seidel C, Beier D, McCabe MG, Grotzer M, Laigle-Donadey F, Stücklin ASG, Idbaih A, Preusser M, van den Bent M, Weller M, Hau P. Franceschi E, et al. Among authors: hattingen e. Lancet Oncol. 2019 Dec;20(12):e715-e728. doi: 10.1016/S1470-2045(19)30669-2. Lancet Oncol. 2019. PMID: 31797797 Review.
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: hattingen e. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Burger MC, Forster MT, Romanski A, Straßheimer F, Macas J, Zeiner PS, Steidl E, Herkt S, Weber KJ, Schupp J, Lun JH, Strecker MI, Wlotzka K, Cakmak P, Opitz C, George R, Mildenberger IC, Nowakowska P, Zhang C, Röder J, Müller E, Ihrig K, Langen KJ, Rieger MA, Herrmann E, Bonig H, Harter PN, Reiss Y, Hattingen E, Rödel F, Plate KH, Tonn T, Senft C, Steinbach JP, Wels WS. Burger MC, et al. Among authors: hattingen e. Neuro Oncol. 2023 Nov 2;25(11):2058-2071. doi: 10.1093/neuonc/noad087. Neuro Oncol. 2023. PMID: 37148198 Free PMC article.
Spinal Intramedullary Tumors.
Neyazi B, Haghikia A, Mawrin C, Hattingen E, Vordermark D, Sandalcioglu IE. Neyazi B, et al. Among authors: hattingen e. Dtsch Arztebl Int. 2024 Dec 13;121(25):840-846. doi: 10.3238/arztebl.m2024.0213. Dtsch Arztebl Int. 2024. PMID: 39628409 Free article. Review.
Imaging of Amyloid-Related Imaging Abnormalities (ARIA).
Urbach H, Linn J, Hattingen E, Fiebach J. Urbach H, et al. Among authors: hattingen e. Rofo. 2024 Apr;196(4):363-369. doi: 10.1055/a-2185-8472. Epub 2023 Nov 23. Rofo. 2024. PMID: 37995736 English, German.
Advances in neuro-oncology imaging.
Langen KJ, Galldiks N, Hattingen E, Shah NJ. Langen KJ, et al. Among authors: hattingen e. Nat Rev Neurol. 2017 May;13(5):279-289. doi: 10.1038/nrneurol.2017.44. Epub 2017 Apr 7. Nat Rev Neurol. 2017. PMID: 28387340 Review.
Imaging Characteristics of Meningiomas.
Galldiks N, Hattingen E, Langen KJ, Tonn JC. Galldiks N, et al. Among authors: hattingen e. Adv Exp Med Biol. 2023;1416:21-33. doi: 10.1007/978-3-031-29750-2_3. Adv Exp Med Biol. 2023. PMID: 37432617
Neuroradiological and clinical features in ophthalmoplegia.
Weidauer S, Hofmann C, Wagner M, Hattingen E. Weidauer S, et al. Among authors: hattingen e. Neuroradiology. 2019 Apr;61(4):365-387. doi: 10.1007/s00234-019-02183-3. Epub 2019 Feb 12. Neuroradiology. 2019. PMID: 30747268 Review.
The neurovasculature as a target in temporal lobe epilepsy.
Reiss Y, Bauer S, David B, Devraj K, Fidan E, Hattingen E, Liebner S, Melzer N, Meuth SG, Rosenow F, Rüber T, Willems LM, Plate KH. Reiss Y, et al. Among authors: hattingen e. Brain Pathol. 2023 Mar;33(2):e13147. doi: 10.1111/bpa.13147. Epub 2023 Jan 4. Brain Pathol. 2023. PMID: 36599709 Free PMC article. Review.
365 results